Cabildo Abierto Una plataforma para discutir en serio, hecha en Argentina.

cabildoabierto.ar/perfil/logo-ped.bsky.social

#MIRAI 2025 #FILM
aepiot.ro/advanced-sea...
#VIMSELTINIB
aepiot.ro/advanced-sea...

aepiot.com

Vimseltinib Approved in EU for Tenosynovial Giant Cell Tumor Vimseltinib has received EU approval for treating tenosynovial giant cell tumor, offering effective outcomes and improved patient quality of life.

Vimseltinib (ROMVIMZA™) Gains European Commission (EC) Approval as First Targeted Therapy for TGCT

oncodaily.com/new-paper-al...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Vimseltinib #ROMVIMZA #TGCT

European Commission approves ROMVIMZA for TGCT treatment - PharmaTimes Vimseltinib becomes first authorised therapy for tenosynovial giant cell tumour in the EU

#ROMVIMZA #Vimseltinib #TGCTtreatment #tenosynovialgiantcelltumour #EU #symptomatictenosynovialgiantcelltumour #TGCT #marketingauthorisation #TGCTtherapy #OnoPharmaceutical #Deciphera #phase3MOTIONstudy #Secondaryendpoints #tumourresponse #stiffness #qualityoflife
pharmatimes.com/news/europea...

Vimseltinib (Romvimza): Uses in Cancer, Side effects, Dosage, Expectations, and more - OncoDaily Learn about Vimseltinib (Romvimza) for TGCT: how it works, approved uses, dosage, side effects, and what patients can expect during treatment.

Vimseltinib (Romvimza): Uses in Cancer, Side effects, Dosage, Expectations, and more

oncodaily.com/drugs/vimsel...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Vimseltinib #Romvimza

FDA approves Deciphera’s Romvimza for rare tumour type - PharmaTimes Tenosynovial giant cell tumours can cause pain, stiffness, swelling and movement limitations

#biopharmaceuticals #DecipheraPharmaceuticals #Romvimza #tenosynovialgiantcelltumours #TGCT #vimseltinib #FDAapprovel #Deciphera #raretumourtype #symptomatictenosynovialgiantcelltumours #tyrosinekinaseinhibitor #CSF1R #CSF1Rinhibitor #MOTIONclinicaltrial
pharmatimes.com/news/fda-app...

FDA Approved Vimseltinib for Tenosynovial Giant Cell Tumor Treatment - OncoDaily FDA Approved Vimseltinib for Tenosynovial Giant Cell Tumor Treatment / Bryan D. Smith, Hans Gelderblom, Maitreyi G. Sharma, Marc Vallee, Matthew L. Sherman,

FDA Approved Vimseltinib for Tenosynovial Giant Cell Tumor Treatment
@fda.gov

oncodaily.com/drugs/244755

#Cancer #CancerTreatment #Medicine #Health #FDA #Vimseltinib #CancerDrug #Oncology #OncoDaily